-- Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025
-- Net Loss of $59.2 million
-- Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025
(Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 2025)
MCLEAN, Va.--(BUSINESS WIRE)--August 07, 2026--
Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the second quarter ended June 30, 2026.
"Claritev once again demonstrated the strength of our vision and strategy in the second quarter of 2026, delivering financial results above expectations with solid execution across the company. We are one year into a transformation program that has seen our company operate with greater clarity, alignment, and focus. This transformation is most notably highlighted by a broader portfolio of solutions, expanded vertical sales markets, heightened focus on AI as both an operational and innovation lever, and a company-wide focus on execution that is building a foundation for long term, sustainable, and ultimately faster growth," said Travis Dalton, Chairman, CEO and President of Claritev.
Mr. Dalton added, "This success is most clearly reflected in our bookings which were spread across solutions and verticals, with notable strength in the TPA market where we closed several seven-figure transactions. With more than $70 million in bookings through the first half of 2026, we are well on our way to achieving our full year target of $100 million which would represent 50% growth over 2025 and is a leading indicator of continued growth in 2027 and beyond."
Doug Garis, Claritev Chief Financial Officer, commented, "Our second quarter results mark five straight quarters of year over year revenue growth, demonstrating the consistency and quality of Claritev's core, and the growth opportunities created by our expansion into new markets and verticals. We have outperformed revenue and Adjusted EBITDA in the first half of the year for the simple reason that our company's #1 focus is on client success. This is true of our sales, product, support and finance teams, augmented by the favorable market trends that helped drive our return to top line growth in 2025. We are particularly happy by the breadth of our bookings which is diversifying our business and serves as the true foundation for delivering against the financial objectives we presented at our Investor Day in March."
Business and Financial Highlights
-- Revenues of $257.5 million for Q2 2026, an increase of 6.6%, compared
to revenues of $241.6 million for Q2 2025.
-- Net loss of $59.2 million for Q2 2026, compared to net loss of $62.6
million for Q2 2025.
-- Adjusted EBITDA of $155.8 million for Q2 2026, an increase of 1.1%,
compared to Adjusted EBITDA of $154.0 million for Q2 2025.
-- Net cash provided by operating activities of $92.7 million for Q2 2026,
compared to net cash provided by operating activities of $61.2 million
for Q2 2025.
-- Free Cash Flow of $54.6 million for Q2 2026, compared to Free Cash Flow
of $36.6 million for Q2 2025.
-- The Company ended Q2 2026 with $14.4 million of unrestricted cash and
cash equivalents on the balance sheet.
2026 Financial Guidance(1)
The Company is updating its full-year 2026 guidance, detailed in the table below:
Financial Metric Prior FY 2026 Guidance Updated FY 2026 Guidance
(as of 5/7/2026) (as of 8/7/2026)
--------------------- ------------------------ ------------------------
$985 million to $1 $1 billion to $1.02
Revenues billion billion
$605 million to $615 $610 million to $620
Adjusted EBITDA(1) million million
$160 million to $170 $160 million to $170
Capital expenditures million million
Effective tax rate 24% to 28% 24% to 28%
Free Cash Flow $0 million to $10 $5 million to $15
million million
Conference Call Information
The Company will host a conference call today, Friday, August 7, 2026 at 8:00 a.m. U.S. Eastern Time $(ET)$ to discuss its financial results. A live webcast of the conference call can be accessed through the Investor Relations section of the Company's website at https://investors.claritev.com/financial-information/quarterly-results. Participants should join the webcast ten minutes prior to the start of the conference call. The earnings press release and supplemental slide deck will also be available on this section of the Company's website.
Participants wishing to join the operator assisted call can dial 646-968-2525 and reference Conference ID 2181839.
A replay of the conference call will be available after the call through the webcast archived on the Investor Relations section of the Company's website.
About Claritev
Claritev is a healthcare technology, data, and insights company focused on delivering affordability, transparency, and quality across the healthcare system. Led by deeply experienced associates, data scientists, and innovators, Claritev provides technology-enabled solutions fueled by decades of claims expertise. The company leverages advanced analytics and AI to power a robust enterprise platform that delivers clear, actionable insights to support affordability, price transparency, and optimized network and benefits design. By supporting key stakeholders -- including payers, employers, patients, providers, and third parties -- Claritev is dedicated to making healthcare more accessible and affordable for all. Claritev serves more than 750 healthcare payers, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.
__________________________________ (1) We have not reconciled the forward-looking Adjusted EBITDA guidance included above to the most directly comparable GAAP (as defined below) measure because this cannot be done without unreasonable effort due to the variability and low visibility with respect to certain costs, the most significant of which are incentive compensation (including stock-based compensation), transaction-related expenses, and certain fair value measurements, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.
Forward Looking Statements
This press release contains forward-looking statements regarding our opinions, beliefs, projections, business plans and expectations. These forward-looking statements may differ materially from actual results due to a variety of factors and can generally be identified by the use of forward-looking terminology, including the terms "believes," "estimates, " "anticipates," "expects," "seeks," "projects," "forecasts," "intends," "plans," "may," "will" or "should" or, in each case, their negative or other variations or comparable terminology. These statements include all matters that are not historical facts. They appear in a number of places throughout this press release, including, but not limited to, statements relating to our ability to deliver anticipated results; our ability to successfully implement our transformation plan; the anticipated growth of our business, including our expansion into new markets and verticals; our 2026 outlook and guidance; and the long-term prospects of the Company. Such forward-looking statements are based on available current market information and management's expectations, beliefs and forecasts concerning future events impacting the business. Although we believe that these forward-looking statements are based on reasonable assumptions at the time they are made, you should be aware that these forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These factors include: loss of, or a significant reduction in the work we do for, our clients, particularly our largest clients; the ability to achieve the goals of our strategic plans and recognize the anticipated strategic, operational, growth and efficiency benefits when expected; our ability to enter new lines of business and broaden the scope of our solutions; trends in the U.S. healthcare system, including recent trends of unknown duration of reduced healthcare utilization and increased patient financial responsibility for services; effects of competition; effects of pricing pressure; the inability of our clients to pay for our solutions; changes in our industry and in industry standards and technology; adverse outcomes related to litigation or governmental proceedings; interruptions or security breaches of our information technology systems and other cybersecurity attacks; our ability to maintain the licenses or right of use for the software we use; our ability to protect proprietary information, processes and applications; our inability to expand our network infrastructure; inability to preserve or increase our existing market share or the size of our preferred provider organization networks; decreases in discounts from providers; pressure to limit access to preferred provider networks; changes in our regulatory environment, including healthcare law and regulations; the expansion of privacy and security laws; heightened enforcement activity by government agencies; our ability to obtain additional financing or capital to meet our objectives; our ability to pay interest and principal on our notes and other indebtedness; lowering or withdrawal of
Comments